CN112458162B - 器官移植ddcfDNA检测试剂和方法 - Google Patents
器官移植ddcfDNA检测试剂和方法 Download PDFInfo
- Publication number
- CN112458162B CN112458162B CN202011280500.7A CN202011280500A CN112458162B CN 112458162 B CN112458162 B CN 112458162B CN 202011280500 A CN202011280500 A CN 202011280500A CN 112458162 B CN112458162 B CN 112458162B
- Authority
- CN
- China
- Prior art keywords
- ddcfdna
- cfdna
- value
- donor
- reads
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000001514 detection method Methods 0.000 title claims abstract description 18
- 238000000034 method Methods 0.000 title claims description 25
- 210000000056 organ Anatomy 0.000 title abstract description 20
- 238000002054 transplantation Methods 0.000 title abstract description 11
- 239000003153 chemical reaction reagent Substances 0.000 title description 13
- 238000006243 chemical reaction Methods 0.000 claims abstract description 8
- 238000002405 diagnostic procedure Methods 0.000 claims abstract description 6
- 239000000523 sample Substances 0.000 claims description 45
- 238000012163 sequencing technique Methods 0.000 claims description 14
- 230000036438 mutation frequency Effects 0.000 claims description 10
- 238000012216 screening Methods 0.000 claims description 10
- 108091023043 Alu Element Proteins 0.000 claims description 9
- 238000005315 distribution function Methods 0.000 claims description 7
- 238000007476 Maximum Likelihood Methods 0.000 claims description 6
- 238000004364 calculation method Methods 0.000 claims description 5
- 238000011002 quantification Methods 0.000 claims description 4
- 238000003753 real-time PCR Methods 0.000 claims description 4
- 238000004458 analytical method Methods 0.000 claims description 3
- 230000035772 mutation Effects 0.000 claims description 3
- 238000002360 preparation method Methods 0.000 claims description 3
- 241000695274 Processa Species 0.000 claims 1
- 238000007481 next generation sequencing Methods 0.000 claims 1
- 230000003252 repetitive effect Effects 0.000 abstract description 5
- 210000002381 plasma Anatomy 0.000 description 23
- 108020004414 DNA Proteins 0.000 description 17
- 230000006870 function Effects 0.000 description 8
- 210000002700 urine Anatomy 0.000 description 6
- 230000006378 damage Effects 0.000 description 5
- 239000006228 supernatant Substances 0.000 description 5
- 108091092584 GDNA Proteins 0.000 description 4
- 238000011529 RT qPCR Methods 0.000 description 4
- 206010052779 Transplant rejections Diseases 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- 239000008280 blood Substances 0.000 description 4
- DDRJAANPRJIHGJ-UHFFFAOYSA-N creatinine Chemical compound CN1CC(=O)NC1=N DDRJAANPRJIHGJ-UHFFFAOYSA-N 0.000 description 4
- 238000013461 design Methods 0.000 description 4
- 239000012634 fragment Substances 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- GUAHPAJOXVYFON-ZETCQYMHSA-N (8S)-8-amino-7-oxononanoic acid zwitterion Chemical compound C[C@H](N)C(=O)CCCCCC(O)=O GUAHPAJOXVYFON-ZETCQYMHSA-N 0.000 description 3
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 3
- 230000006907 apoptotic process Effects 0.000 description 3
- 238000001574 biopsy Methods 0.000 description 3
- 238000000605 extraction Methods 0.000 description 3
- 238000012544 monitoring process Methods 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 230000035945 sensitivity Effects 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 210000000349 chromosome Anatomy 0.000 description 2
- 238000010276 construction Methods 0.000 description 2
- 229940109239 creatinine Drugs 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 230000017074 necrotic cell death Effects 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 238000001179 sorption measurement Methods 0.000 description 2
- 102100034032 Cytohesin-3 Human genes 0.000 description 1
- 101710160297 Cytohesin-3 Proteins 0.000 description 1
- 102000053602 DNA Human genes 0.000 description 1
- 238000007400 DNA extraction Methods 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 206010061481 Renal injury Diseases 0.000 description 1
- 108091081062 Repeated sequence (DNA) Proteins 0.000 description 1
- 101100495925 Schizosaccharomyces pombe (strain 972 / ATCC 24843) chr3 gene Proteins 0.000 description 1
- 210000002593 Y chromosome Anatomy 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 229940127219 anticoagulant drug Drugs 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 238000003149 assay kit Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000000090 biomarker Substances 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 210000001175 cerebrospinal fluid Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 238000007405 data analysis Methods 0.000 description 1
- 238000012217 deletion Methods 0.000 description 1
- 230000037430 deletion Effects 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000024924 glomerular filtration Effects 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 208000037806 kidney injury Diseases 0.000 description 1
- 230000000873 masking effect Effects 0.000 description 1
- 238000010369 molecular cloning Methods 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 238000010827 pathological analysis Methods 0.000 description 1
- 210000005259 peripheral blood Anatomy 0.000 description 1
- 239000011886 peripheral blood Substances 0.000 description 1
- 238000003793 prenatal diagnosis Methods 0.000 description 1
- 238000003908 quality control method Methods 0.000 description 1
- 239000002096 quantum dot Substances 0.000 description 1
- 238000011897 real-time detection Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 230000000472 traumatic effect Effects 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
- C12Q1/6851—Quantitative amplification
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/118—Prognosis of disease development
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Analytical Chemistry (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Medical Informatics (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Artificial Intelligence (AREA)
- Evolutionary Computation (AREA)
- Bioethics (AREA)
- Computer Vision & Pattern Recognition (AREA)
- Data Mining & Analysis (AREA)
- Databases & Information Systems (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pathology (AREA)
- Public Health (AREA)
- Software Systems (AREA)
- Bioinformatics & Computational Biology (AREA)
- Evolutionary Biology (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Theoretical Computer Science (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Description
引物名称 | 引物序列 | Seq NO |
ALU81-F | 5'-CCTGAGGTCAGGAGTTCGAG-3' | 1 |
ALU81-R | 5'-GCCCCGGCTAATTTTTGTAT-3' | 2 |
ALU115-F | 5'-CCTGAGGTCAGGAGTTCGAG-3' | 3 |
ALU115-R | 5'-CCCGAGTAGCTGGGATTACA-3' | 4 |
组分 | 体积 |
KAPA SYBR FAST Mastermix | 10µL |
正向引物(10µM) | 0.4µL |
反向引物(10µM) | 0.4µL |
DMSO | 1.2µL |
gDNA | 2µL |
ROX Low | 0.4µL |
<![CDATA[H<sub>2</sub>O]]> | <![CDATA[补H<sub>2</sub>O至20µL]]> |
样本编号 | 1mL血浆cfDNA的量(ng/mL)-qubit结果 | 1mL血浆cfDNA的量(ng/mL)-qPCR结果 |
1 | 59.28 | 29.4 |
2 | 144.56 | 96.8 |
3 | 39.416 | 21.4 |
4 | 44.2 | 31.4 |
5 | 32.604 | 6.1 |
6 | 122.2 | 86.9 |
7 | 32.448 | 7.6 |
rs | 染色体 | 位置 | rs | 染色体 | 位置 |
rs1490413 | chr1 | 4367323 | rs3764570 | chr19 | 8528277 |
rs3740199 | chr10 | 128019025 | rs528557 | chr20 | 3651742 |
rs10488710 | chr11 | 115207176 | rs3205187 | chr22 | 31491295 |
rs10831567 | chr11 | 11292700 | rs743616 | chr22 | 51064039 |
rs1169289 | chr12 | 121416622 | rs13071423 | chr3 | 2140378 |
rs12825673 | chr12 | 569945 | rs6835017 | chr4 | 20182928 |
rs4530059 | chr14 | 104769149 | rs16870629 | chr5 | 1015063 |
rs2306049 | chr16 | 88767769 | rs62490396 | chr7 | 1.4E+08 |
rs213656 | chr16 | 1113847 | rs6954783 | chr7 | 1036512 |
rs4605160 | chr16 | 9187721 | rs6950990 | chr7 | 1536566 |
rs2293067 | chr17 | 1550106 | rs2519123 | chr9 | 1.37E+08 |
rs3809972 | chr18 | 56204945 | rs10815156 | chr9 | 518755 |
rs9303995 | chr18 | 7230612 | rs10738558 | chr9 | 2023316 |
样本编号 | 算法1相对含量 | 算法2相对含量 | 算法3相对含量 |
1 | 0.0038 | 0.0022 | 0.0058 |
2 | 0.0038 | 0.002 | 0.0056 |
3 | 0.0087 | 0.0028 | 0.0131 |
4 | 0.0036 | 0.0025 | 0.0054 |
5 | 0.0193 | 0.0179 | 0.029 |
6 | 0.0011 | 0.0007 | 0.0017 |
7 | 0.0233 | 0.0138 | 0.0349 |
样本编号 | 算法1相对值评分 | 算法1检测结果 | 算法2相对值评分 | 算法2检测结果 | 算法3相对值评分 | 算法3检测结果 | 临床检测结果 |
1 | 0.113 | 否 | 0.065 | 否 | 0.170 | 否 | 否 |
2 | 0.364 | 是 | 0.194 | 否 | 0.542 | 是 | 是 |
3 | 0.187 | 否 | 0.060 | 否 | 0.281 | 是 | 是 |
4 | 0.113 | 否 | 0.078 | 否 | 0.170 | 否 | 否 |
5 | 0.118 | 否 | 0.109 | 否 | 0.176 | 否 | 否 |
6 | 0.097 | 否 | 0.061 | 否 | 0.148 | 否 | 否 |
7 | 0.177 | 否 | 0.105 | 否 | 0.266 | 是 | 是 |
Claims (4)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202011280500.7A CN112458162B (zh) | 2020-11-16 | 2020-11-16 | 器官移植ddcfDNA检测试剂和方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202011280500.7A CN112458162B (zh) | 2020-11-16 | 2020-11-16 | 器官移植ddcfDNA检测试剂和方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN112458162A CN112458162A (zh) | 2021-03-09 |
CN112458162B true CN112458162B (zh) | 2023-04-18 |
Family
ID=74837072
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202011280500.7A Active CN112458162B (zh) | 2020-11-16 | 2020-11-16 | 器官移植ddcfDNA检测试剂和方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN112458162B (zh) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2023116717A1 (en) * | 2021-12-22 | 2023-06-29 | The First Affiliated Hospital Of Guangzhou Medical University | Method for monitoring donar dna fraction |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105102634A (zh) * | 2013-03-15 | 2015-11-25 | 伊穆科Gti诊治股份有限公司 | 使用尿的无细胞dna评价肾状态的方法和组合物 |
CN109887548A (zh) * | 2019-01-18 | 2019-06-14 | 臻悦生物科技江苏有限公司 | 基于捕获测序的ctDNA占比的检测方法及检测装置 |
CN110770840A (zh) * | 2017-06-20 | 2020-02-07 | 伊鲁米那股份有限公司 | 用于对来自已知或未知基因型的多个贡献者的dna混合物分解和定量的方法和系统 |
WO2020185967A1 (en) * | 2019-03-11 | 2020-09-17 | Red Genomics, Inc. | Methods and reagents for enhanced next generation sequencing library conversion and insertion of barcodes into nucleic acids. |
-
2020
- 2020-11-16 CN CN202011280500.7A patent/CN112458162B/zh active Active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105102634A (zh) * | 2013-03-15 | 2015-11-25 | 伊穆科Gti诊治股份有限公司 | 使用尿的无细胞dna评价肾状态的方法和组合物 |
CN110770840A (zh) * | 2017-06-20 | 2020-02-07 | 伊鲁米那股份有限公司 | 用于对来自已知或未知基因型的多个贡献者的dna混合物分解和定量的方法和系统 |
CN109887548A (zh) * | 2019-01-18 | 2019-06-14 | 臻悦生物科技江苏有限公司 | 基于捕获测序的ctDNA占比的检测方法及检测装置 |
WO2020185967A1 (en) * | 2019-03-11 | 2020-09-17 | Red Genomics, Inc. | Methods and reagents for enhanced next generation sequencing library conversion and insertion of barcodes into nucleic acids. |
Also Published As
Publication number | Publication date |
---|---|
CN112458162A (zh) | 2021-03-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US11519031B2 (en) | Non-invasive prenatal diagnosis of fetal genetic condition using cellular DNA and cell free DNA | |
US20210108262A1 (en) | Error suppression in sequenced dna fragments using redundant reads with unique molecular indices (umis) | |
JP7051900B2 (ja) | 不均一分子長を有するユニーク分子インデックスセットの生成およびエラー補正のための方法およびシステム | |
CN107254514B (zh) | 检测异源cfDNA的SNP分子标记及检测方法、用途 | |
US20180068058A1 (en) | Methods and compositions for sample identification | |
KR20150067161A (ko) | 희귀 돌연변이 및 카피수 변이를 검출하기 위한 시스템 및 방법 | |
CA2569531A1 (en) | Gene expression analysis for identification of tumor types | |
CN109504784B (zh) | 用于预测人辅助生殖技术中早期胚胎质量的miRNA分子标志及其应用 | |
WO2008103971A2 (en) | Prostate cancer survival and recurrence | |
CN110229897A (zh) | Med12基因突变检测试剂盒及其应用 | |
CN113724862B (zh) | 一种结直肠癌生物标志物及其筛选方法和应用 | |
CN112458162B (zh) | 器官移植ddcfDNA检测试剂和方法 | |
CN113151434A (zh) | Snp标志物、应用及引物、探针、肺移植物排斥风险试剂盒 | |
CN111944893B (zh) | 与唇腭裂产前无创诊断相关的miRNA分子标志物及其应用 | |
US20100047787A1 (en) | Prostate cancer survival and recurrence | |
KR20210071983A (ko) | 임산부로부터 분리된 순환 페탈 세포가 현재 또는 과거의 임신의 것인지 확인하는 방법 | |
EP3202912A1 (en) | Noninvasive method and system for determining fetal chromosomal aneuploidy | |
RU2766198C9 (ru) | Способы и системы для получения наборов уникальных молекулярных индексов с гетерогенной длиной молекул и коррекции в них ошибок | |
CN106834491B (zh) | 乳腺癌预后相关基因突变检测试剂盒及其使用方法 | |
CN114517232A (zh) | 无创方式判断子宫内膜容受性的方法、模型和标志物 | |
CN117802243A (zh) | 用于肝癌诊断的miRNA标志物、试剂、试剂盒及诊断系统 | |
CN115992219A (zh) | Tomm6突变基因、检测其的引物、试剂盒和方法以及其用途 | |
CN113981058A (zh) | 用于检测人hla-b*8基因的引物组、探针、试剂盒和方法 | |
CN110331206A (zh) | 辅助诊断肺腺癌的基因标志物及其用途 | |
CN108220427A (zh) | 一种用于鉴别诊断BHD综合征与原发性自发性气胸的血浆microRNA标记物及应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20240319 Address after: 400000 1-2, 2-2, 3-2, 4-2, 5-2, 6-2, building 1, No. 6, Gangcheng East Ring Road, Jiangbei District, Chongqing Patentee after: MYGENOSTICS (CHONGQING) GENE TECHNOLOGY CO.,LTD. Country or region after: Zhong Guo Address before: 101312 201, block a, building 12, courtyard 9, Anqing street, airport economic core area, Shunyi District, Beijing Patentee before: BEIJING MYGENOSTICS CO.,LTD. Country or region before: Zhong Guo |
|
TR01 | Transfer of patent right |